|
ZC3HC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.075650E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.483840E-01 |
| Normal-vs-Stage2 |
1.422090E-02 |
| Normal-vs-Stage3 |
2.614300E-02 |
| Normal-vs-Stage4 |
5.718600E-03 |
| Stage1-vs-Stage2 |
1.609930E-04 |
| Stage1-vs-Stage3 |
2.037200E-01 |
| Stage1-vs-Stage4 |
2.021600E-02 |
| Stage2-vs-Stage3 |
9.54180000000138E-05 |
| Stage2-vs-Stage4 |
4.16680000000502E-05 |
| Stage3-vs-Stage4 |
2.521600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.483700E-02 |
| Normal-vs-AfricanAmerican |
2.121800E-01 |
| Normal-vs-Asian |
3.725400E-01 |
| Caucasian-vs-AfricanAmerican |
7.006400E-01 |
| Caucasian-vs-Asian |
3.557500E-02 |
| AfricanAmerican-vs-Asian |
7.503600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.245760E-01 |
| Normal-vs-Female |
1.598220E-01 |
| Male-vs-Female |
6.306200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.277800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.047400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.712200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.301400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.993400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.868400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.041800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.502400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.012600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.950800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.208400E-04 |
| Classical-VS-Follicular |
1.241910E-02 |
| Classical-VS-Other |
3.707000E-01 |
| Classical-VS-Normal |
1.507620E-01 |
| Tall-VS-Follicular |
2.81390000000936E-06 |
| Tall-VS-Other |
5.670200E-01 |
| Tall-VS-Normal |
2.43259999999079E-05 |
| Follicular-VS-Other |
8.836500E-02 |
| Follicular-VS-Normal |
2.495600E-01 |
| Other-VS-Normal |
6.334000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.369200E-01 |
| Normal-vs-N1 |
2.200400E-02 |
| N0-vs-N1 |
1.140310E-02 |
|
|
